Amplitude Surgical reported FY 1Q21 orthopedic revenue of €21.6 million (USD $24.3 million), +3.6% vs. FY 1Q20. Domestic sales in France grew 17%, but were offset by the impact of COVID in markets like Australia and Brazil. The company’s foot and ankle business, Novastep, recorded steep growth driven by sales in France and the U.S.
The second wave of rapid COVID spread led to access restrictions for operating rooms in some European markets. Amplitude measured a -30% decrease in activity for the final week of October and first weeks of November 2020 compared to the prior year.
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
1Q20
1Q19
$ Chg
% Chg
Joint Replacement
$23.1
$22.3
$0.8
3.7%
Knees
$11.9
$11.9
$0.0
0.3%
Hips
$8.5
$8.2
$0.3
3.6%
Trauma
$2.7
$2.2
$0.5
22.3%
Sports Medicine
$0.7
$0.7
$0.0
0.1%
Orthobiologics
$0.5
$0.5
$0.0
3.6%
Total
$24.3
$23.4
$0.8
3.6%
Geographic Sales
1Q20
1Q19
$ Chg
% Chg
France
$15.9
$13.6
$2.3
17%
International
$8.4
$9.8
($1.5)
(15%)
Subsidiaries
$6.2
$7.7
($1.5)
(19%)
Distributors
$2.2
$2.2
($0.0)
(0.7%)
Total
$24.3
$23.4
$0.8
3.6%
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
Amplitude Surgical reported FY 1Q21 orthopedic revenue of €21.6 million (USD $24.3 million), +3.6% vs. FY 1Q20. Domestic sales in France grew 17%, but were offset by the impact of COVID in markets like Australia and Brazil. The company’s foot and ankle business, Novastep, recorded steep growth driven by sales in France and the U.S.
The...
Amplitude Surgical reported FY 1Q21 orthopedic revenue of €21.6 million (USD $24.3 million), +3.6% vs. FY 1Q20. Domestic sales in France grew 17%, but were offset by the impact of COVID in markets like Australia and Brazil. The company’s foot and ankle business, Novastep, recorded steep growth driven by sales in France and the U.S.
The second wave of rapid COVID spread led to access restrictions for operating rooms in some European markets. Amplitude measured a -30% decrease in activity for the final week of October and first weeks of November 2020 compared to the prior year.
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
1Q20
1Q19
$ Chg
% Chg
Joint Replacement
$23.1
$22.3
$0.8
3.7%
Knees
$11.9
$11.9
$0.0
0.3%
Hips
$8.5
$8.2
$0.3
3.6%
Trauma
$2.7
$2.2
$0.5
22.3%
Sports Medicine
$0.7
$0.7
$0.0
0.1%
Orthobiologics
$0.5
$0.5
$0.0
3.6%
Total
$24.3
$23.4
$0.8
3.6%
Geographic Sales
1Q20
1Q19
$ Chg
% Chg
France
$15.9
$13.6
$2.3
17%
International
$8.4
$9.8
($1.5)
(15%)
Subsidiaries
$6.2
$7.7
($1.5)
(19%)
Distributors
$2.2
$2.2
($0.0)
(0.7%)
Total
$24.3
$23.4
$0.8
3.6%
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
